about
Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV proteaseQuantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues.Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIVCXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapyFine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.FIV Gag: virus assembly and host-cell interactions.Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gagInterplay between HIV entry and transportin-SR2 dependencyInflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress.Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Label-free capacitance-based identification of virusesMapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.The secondary structure of the 5' end of the FIV genome reveals a long-range interaction between R/U5 and gag sequences, and a large, stable stem-loopAn EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860
Q27668150-A691FF43-54E3-4CA0-89A5-B2E4F1D753A0Q30492706-833005FC-1961-48ED-BCF1-FD30A12FCECCQ33515462-673C395D-FE7D-4412-BF08-15B55A8F41A5Q33552227-B4F3C9C2-B94B-4E91-B848-E2078E99DDFDQ33587317-E11EE72C-29E5-4623-B9F9-A8A37321AB4FQ33653971-CB18AA9A-A5B0-49B1-BDC9-64B1725A8F58Q33987860-5BE515F0-C33C-4DB3-BF3E-F42348E117FEQ33990752-C1399040-CB05-4342-817D-67ED34AEA70EQ34195197-1789D29D-6F2C-424B-97EA-968409451BC2Q34329784-34E04510-6A7D-4CCB-AF11-80BD25514B9FQ34586080-70F4013D-D844-4B5F-A5BB-3D716758C9C0Q35043873-AAD24644-E517-475A-BC10-3C966C5FB36BQ35077801-F825E031-696A-4DDE-A264-3090D2084949Q35599236-6640D09E-3BAC-418B-89C8-A5F1B1E6EC86Q36470890-CCB63C23-D72B-412A-AE4E-6967441029FCQ36990757-5535DA6A-948E-4641-8682-FF1984F6FD9DQ37405780-07738E19-6E97-4721-98FF-A15BD122219CQ37619606-498C7446-2887-4A97-8598-FD0C0AB8D085Q52574472-727055A9-48C4-46AA-A609-379AD1E9E2B7Q53686365-EFAC84B3-31A0-4345-B229-2DD0527FD6A3
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular mechanisms of FIV infection.
@ast
Molecular mechanisms of FIV infection.
@en
type
label
Molecular mechanisms of FIV infection.
@ast
Molecular mechanisms of FIV infection.
@en
prefLabel
Molecular mechanisms of FIV infection.
@ast
Molecular mechanisms of FIV infection.
@en
P2093
P2860
P1476
Molecular mechanisms of FIV infection.
@en
P2093
Aymeric de Parseval
Chris K Grant
John H Elder
Magnus Sundstrom
Sohela de Rozieres
Ying-Chuan Lin
P2860
P356
10.1016/J.VETIMM.2008.01.007
P577
2008-01-19T00:00:00Z